Pharmaceutical Stocks To Watch Now – June 16th

Eli Lilly and Company, D-Wave Quantum, and Sarepta Therapeutics are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture and market medicinal drugs and therapies. Their performance is driven by factors such as clinical‐trial results, regulatory approvals, patent lifecycles and overall healthcare market demand. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY traded down $8.65 during mid-day trading on Monday, reaching $810.71. 1,676,140 shares of the stock traded hands, compared to its average volume of 3,650,683. The firm has a fifty day moving average price of $775.43 and a 200 day moving average price of $801.69. The company has a current ratio of 1.15, a quick ratio of 0.97 and a debt-to-equity ratio of 2.00. Eli Lilly and Company has a 1 year low of $677.09 and a 1 year high of $972.53. The company has a market cap of $768.34 billion, a price-to-earnings ratio of 69.24, a price-to-earnings-growth ratio of 1.40 and a beta of 0.40.

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

Shares of QBTS traded up $0.90 during trading hours on Monday, reaching $16.07. 47,717,719 shares of the company traded hands, compared to its average volume of 46,045,227. D-Wave Quantum has a 12 month low of $0.75 and a 12 month high of $19.77. The company has a market capitalization of $4.69 billion, a price-to-earnings ratio of -38.18 and a beta of 1.49. The company’s fifty day moving average price is $11.54 and its two-hundred day moving average price is $8.31.

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene.

Sarepta Therapeutics stock traded down $15.62 during mid-day trading on Monday, hitting $20.56. The company had a trading volume of 31,976,154 shares, compared to its average volume of 1,936,096. Sarepta Therapeutics has a 12 month low of $18.33 and a 12 month high of $173.25. The stock’s 50 day moving average price is $46.25 and its two-hundred day moving average price is $86.03. The company has a current ratio of 3.84, a quick ratio of 3.03 and a debt-to-equity ratio of 0.93. The company has a market capitalization of $2.02 billion, a PE ratio of 16.42 and a beta of 0.61.